Public Mergers & Acquisitions (US & Non-US Targets) Deal Point Data rankings include mergers & acquisitions with a US or non-US public target and at least one SEC filer participant. Top Target and Acquirer M&A Attorney Advisers Created: 10/Aug/2016 www.dealpointdata.com/ranking Search Criteria Target industry: Healthcare
Equity Value Equity Value Equity Value % Rank Rank $m $m Change Deal Count Deal Count 2016 2015 Attorney 2016 2015 2015 to 2016 2016 2015 David K. Lam - Wachtell, Lipton, 1 1 Rosen & Katz 28,588 163,176 -82 2 2 Edward D. Herlihy - Wachtell, 1 1 Lipton, Rosen & Katz 28,588 163,176 -82 2 2 Christopher D. Dillon - Gibson, 3 44 Dunn & Crutcher LLP 24,085 3,442 600 1 1 Dennis J. Friedman - Gibson, 3 - Dunn & Crutcher LLP 24,085 - - 1 0 Joseph Barbeau - Gibson, Dunn 3 44 & Crutcher LLP 24,085 3,442 600 1 1 Victor Goldfeld - Wachtell, 3 - Lipton, Rosen & Katz 24,085 - - 1 0
7 10 Daniel Wolf - Kirkland & Ellis LLP 6,464 30,919 -79 3 1 David Feirstein - Kirkland & Ellis 8 - LLP 6,115 - - 2 0 Kevin A. Rinker - Debevoise & 9 - Plimpton LLP 4,905 - - 1 0 Paul S. Bird - Debevoise & 9 - Plimpton LLP 4,905 - - 1 0 J. James Jenkins, Jr. - Bass, 9 - Berry & Sims PLC 4,905 - - 1 0 Michael Davis - Davis Polk & 12 - Wardwell LLP 4,852 - - 2 0 O. Keith Hallam - Cravath, 13 - Swaine & Moore LLP 4,830 - - 1 0 Scott A. Barshay - Cravath, 13 - Swaine & Moore LLP 4,830 - - 1 0 H. Oliver Smith - Davis Polk & 15 - Wardwell LLP 4,503 - - 1 0 16 43 Barbara L. Borden - Cooley LLP 1,571 4,169 -62 2 2 Josh Dubofsky - Latham & 17 55 Watkins LLP 1,432 1,936 -26 1 1 Mark Roeder - Latham & Watkins 17 - LLP 1,432 - - 1 0 17 - Andrew M. Levine - Jones Day 1,432 - - 1 0 17 - Jeffrey Symons - Jones Day 1,432 - - 1 0 Carmelo Gordian - Andrews 21 - Kurth LLP 1,082 - - 1 0 J. Russel Denton - Andrews 21 - Kurth LLP 1,082 - - 1 0 Chang-Do Gong - White & Case 21 96 LLP 1,082 97 1015 1 1 Morton A. Pierce - White & Case 21 - LLP 1,082 - - 1 0 Paul Kinsella - Ropes & Gray, 25 9 LLP 1,060 54,541 -98 2 3 Clare O'Brien - Shearman & 26 - Sterling LLP 1,017 - - 1 0 Robert M. Katz - Shearman & 26 - Sterling LLP 1,017 - - 1 0 Christopher Comeau - Ropes & 26 10 Gray, LLP 1,017 30,919 -97 1 1 Alexander D. Fine - Kirkland & 29 - Ellis LLP 714 - - 1 0 George P. Stamas - Kirkland & 29 - Ellis LLP 714 - - 1 0 William B. Sorabella - Kirkland & 29 - Ellis LLP 714 - - 1 0 Masakazu Iwakura - Nishimura & 29 - Asahi 714 - - 1 0
Scott Grader - Paul, Weiss, 29 - Rifkind, Wharton & Garrison LLP 714 - - 1 0
Toby S. Myerson - Paul, Weiss, 29 - Rifkind, Wharton & Garrison LLP 714 - - 1 0 Christopher R. Moore - Weil 35 - Gotshal & Manges LLP 447 - - 1 0 Keith Flaum - Weil Gotshal & 35 - Manges LLP 447 - - 1 0 35 - Mark Ray - Alston & Bird, LLP 447 - - 1 0 Klaus Ilmonen - Hannes 38 - Snellman 349 - - 1 0 Mikko Heinonen - Hannes 38 - Snellman 349 - - 1 0 Sophia Hudson - Davis Polk & 38 - Wardwell LLP 349 - - 1 0 Antti Ihamuotila - Roschier, 38 - Attorneys Ltd 349 - - 1 0 Joshua Zachariah - Kirkland & 38 - Ellis LLP 349 - - 1 0 Paula Linna - Roschier, 38 - Attorneys Ltd 349 - - 1 0 44 - Kay Chandler - Cooley LLP 286 - - 1 0 Rama Padmanabhan - Cooley 44 48 LLP 286 3,213 -91 1 1 44 - Michael J. Silver - Hogan Lovells 286 - - 1 0 47 - Jay E. Bothwick - WilmerHale 264 - - 1 0 Cary K. Hyden - Latham & 47 - Watkins LLP 264 - - 1 0 Michael A. Treska - Latham & 47 - Watkins LLP 264 - - 1 0 James T. Lidbury - Ropes & 50 - Gray, LLP 141 - - 1 0 Rachel Phillips - Ropes & Gray, 50 - LLP 141 - - 1 0 Sean P. Griffiths - Gibson, Dunn 50 - & Crutcher LLP 141 - - 1 0 Blake Hornick - Seyfarth Shaw 53 - LLP 85 - - 1 0 Jonathan M. Minnen - Smith, 53 - Gambrell & Russell, LLP 85 - - 1 0 Sharon R. Flanagan - Sidley 55 - Austin 75 - - 1 0 Michael J. O'Donnell - Morrison & 55 - Foerster, LLP 75 - - 1 0 Michael J. Bennett - McCarthy 57 - Tetrault LLP 60 - - 1 0 Joshua M. Samek - Greenberg 57 - Traurig, LLP 60 - - 1 0 Robert L. Grossman - Greenberg 57 58 Traurig, LLP 60 1,532 -96 1 2 Raymond O. Gietz - Weil Gotshal 60 105 & Manges LLP 43 35 23 1 1 61 - Brent D. Fassett - Cooley LLP 17 - - 1 0 Neil P. Stronski - Skadden, Arps, 61 - Slate, Meagher & Flom LLP 17 - - 1 0
Paul T. Schnell - Skadden, Arps, 61 - Slate, Meagher & Flom LLP 17 - - 1 0 Gregory W. Gribben - Woods 64 - Oviatt Gilman LLP 12 - - 1 0 Sean D. Jensen - Woods Oviatt 64 - Gilman LLP 12 - - 1 0 Flora R. Perez - Greenberg 64 - Traurig, LLP 12 - - 1 0 Matthew Miller - Greenberg 64 - Traurig, LLP 12 - - 1 0
David K. Lam Anacor Pharmaceuticals, Inc./Pfizer Inc. $4,503m St. Jude Medical, Inc./Abbott Laboratories $24,085m
Edward D. Herlihy Anacor Pharmaceuticals, Inc./Pfizer Inc. $4,503m St. Jude Medical, Inc./Abbott Laboratories $24,085m
Christopher D. Dillon St. Jude Medical, Inc./Abbott Laboratories $24,085m
Dennis J. Friedman St. Jude Medical, Inc./Abbott Laboratories $24,085m
Joseph Barbeau St. Jude Medical, Inc./Abbott Laboratories $24,085m
Victor Goldfeld St. Jude Medical, Inc./Abbott Laboratories $24,085m
Daniel Wolf Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m Celator Pharmaceuticals, Inc./Jazz Pharmaceuticals plc $1,285m
David Feirstein Alere Inc./Abbott Laboratories $4,830m Celator Pharmaceuticals, Inc./Jazz Pharmaceuticals plc $1,285m Kevin A. Rinker Envision Healthcare Holdings, Inc./AmSurg Corp. $4,905m
Paul S. Bird Envision Healthcare Holdings, Inc./AmSurg Corp. $4,905m
J. James Jenkins, Jr. Envision Healthcare Holdings, Inc./AmSurg Corp. $4,905m
Michael Davis Anacor Pharmaceuticals, Inc./Pfizer Inc. $4,503m Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
O. Keith Hallam Alere Inc./Abbott Laboratories $4,830m
Scott A. Barshay Alere Inc./Abbott Laboratories $4,830m
H. Oliver Smith Anacor Pharmaceuticals, Inc./Pfizer Inc. $4,503m
Barbara L. Borden Celator Pharmaceuticals, Inc./Jazz Pharmaceuticals plc $1,285m Sequenom, Inc./Laboratory Corporation of America Holdings $286m
Josh Dubofsky Relypsa, Inc./Galenica AG $1,432m
Mark Roeder Relypsa, Inc./Galenica AG $1,432m
Andrew M. Levine Relypsa, Inc./Galenica AG $1,432m
Jeffrey Symons Relypsa, Inc./Galenica AG $1,432m
Carmelo Gordian LDR Holding Corporation/Zimmer Biomet Holdings, Inc. $1,082m
J. Russel Denton LDR Holding Corporation/Zimmer Biomet Holdings, Inc. $1,082m Chang-Do Gong LDR Holding Corporation/Zimmer Biomet Holdings, Inc. $1,082m
Morton A. Pierce LDR Holding Corporation/Zimmer Biomet Holdings, Inc. $1,082m
Paul Kinsella Aegerion Pharmaceuticals, Inc./QLT Inc. $43m HeartWare International, Inc./Medtronic Public Limited Company $1,017m
Clare O'Brien HeartWare International, Inc./Medtronic Public Limited Company $1,017m
Robert M. Katz HeartWare International, Inc./Medtronic Public Limited Company $1,017m
Christopher Comeau HeartWare International, Inc./Medtronic Public Limited Company $1,017m
Alexander D. Fine Sagent Pharmaceuticals, Inc./Nichi-Iko Pharmaceutical Co., Ltd. $714m
George P. Stamas Sagent Pharmaceuticals, Inc./Nichi-Iko Pharmaceutical Co., Ltd. $714m
William B. Sorabella Sagent Pharmaceuticals, Inc./Nichi-Iko Pharmaceutical Co., Ltd. $714m
Masakazu Iwakura Sagent Pharmaceuticals, Inc./Nichi-Iko Pharmaceutical Co., Ltd. $714m
Scott Grader Sagent Pharmaceuticals, Inc./Nichi-Iko Pharmaceutical Co., Ltd. $714m
Toby S. Myerson Sagent Pharmaceuticals, Inc./Nichi-Iko Pharmaceutical Co., Ltd. $714m
Christopher R. Moore XenoPort, Inc./Arbor Pharmaceuticals, LLC $447m
Keith Flaum XenoPort, Inc./Arbor Pharmaceuticals, LLC $447m Mark Ray XenoPort, Inc./Arbor Pharmaceuticals, LLC $447m
Klaus Ilmonen Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
Mikko Heinonen Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
Sophia Hudson Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
Antti Ihamuotila Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
Joshua Zachariah Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
Paula Linna Biotie Therapies Oyj/Acorda Therapeutics, Inc. $349m
Kay Chandler Sequenom, Inc./Laboratory Corporation of America Holdings $286m
Rama Padmanabhan Sequenom, Inc./Laboratory Corporation of America Holdings $286m
Michael J. Silver Sequenom, Inc./Laboratory Corporation of America Holdings $286m
Jay E. Bothwick American Science and Engineering, Inc./OSI Systems, Inc. $264m
Cary K. Hyden American Science and Engineering, Inc./OSI Systems, Inc. $264m
Michael A. Treska American Science and Engineering, Inc./OSI Systems, Inc. $264m
James T. Lidbury Symmetry Surgical Inc./RoundTable Healthcare Partners L.P. $141m Rachel Phillips Symmetry Surgical Inc./RoundTable Healthcare Partners L.P. $141m
Sean P. Griffiths Symmetry Surgical Inc./RoundTable Healthcare Partners L.P. $141m
Blake Hornick Nanosphere, Inc./Luminex Corporation $85m
Jonathan M. Minnen Nanosphere, Inc./Luminex Corporation $85m
Sharon R. Flanagan Hansen Medical, Inc./Auris Surgical Robotics Inc. $75m
Michael J. O'Donnell Hansen Medical, Inc./Auris Surgical Robotics Inc. $75m
Michael J. Bennett Transition Therapeutics Inc./OPKO Health, Inc. $60m
Joshua M. Samek Transition Therapeutics Inc./OPKO Health, Inc. $60m
Robert L. Grossman Transition Therapeutics Inc./OPKO Health, Inc. $60m
Raymond O. Gietz Aegerion Pharmaceuticals, Inc./QLT Inc. $43m
Brent D. Fassett Alexza Pharmaceuticals, Inc./Grupo Ferrer Internacional, S.A. $17m
Neil P. Stronski Alexza Pharmaceuticals, Inc./Grupo Ferrer Internacional, S.A. $17m
Paul T. Schnell Alexza Pharmaceuticals, Inc./Grupo Ferrer Internacional, S.A. $17m
Gregory W. Gribben VirtualScopics, Inc./BioTelemetry, Inc. $12m
Sean D. Jensen VirtualScopics, Inc./BioTelemetry, Inc. $12m
Flora R. Perez VirtualScopics, Inc./BioTelemetry, Inc. $12m
Matthew Miller VirtualScopics, Inc./BioTelemetry, Inc. $12m